Universe Pharmaceuticals Announces Share Consolidation
Ticker: UPC · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-consolidation, corporate-action
Related Tickers: UNVP
TL;DR
UNVP consolidates 100 shares into 1, effective March 20, 2025.
AI Summary
Universe Pharmaceuticals INC announced a share consolidation, effective March 20, 2025. This move aims to adjust the number of outstanding ordinary shares, with every 100 existing shares being consolidated into 1 new ordinary share. The company's principal executive offices are located at 265 Jingjiu Avenue, Ji'an, Jiangxi, China.
Why It Matters
Share consolidations can impact a company's stock price and trading dynamics, potentially making it more attractive to institutional investors by increasing the per-share price.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a corporate action (share consolidation) and does not contain significant financial or operational news.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the report and subject of the announcement
- March 20, 2025 (date) — Effective date of the share consolidation
- 100 (number) — Ratio of share consolidation (100 old shares for 1 new share)
FAQ
What is the purpose of the share consolidation announced by Universe Pharmaceuticals INC?
The filing states that the share consolidation is to adjust the number of outstanding ordinary shares of the company.
What is the ratio of the share consolidation?
Every 100 existing ordinary shares are consolidated into 1 new ordinary share.
When is the share consolidation effective?
The share consolidation is effective as of March 20, 2025.
What is the company's primary business address?
The company's principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
Does Universe Pharmaceuticals INC file annual reports under Form 20-F or 40-F?
Universe Pharmaceuticals INC files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding Universe Pharmaceuticals INC (UPC).